Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluoxetine hydrochloride |
Is a |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Prozac measurement |
Component |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine poisoning |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental fluoxetine poisoning |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional fluoxetine poisoning |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la fluoxétine d'intention indéterminée |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional fluvoxamine poisoning |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine adverse reaction |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to fluoxetine |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine overdose |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental fluoxetine overdose |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional fluoxetine overdose |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de fluoxétine d'intention indéterminée |
Causative agent (attribute) |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral fluoxetine m/r capsule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine 90mg capsule delayed release (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluoxetine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluoxetine and olanzapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine hydrochloride 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental fluoxetine poisoning |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional fluoxetine poisoning |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine measurement |
Component |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluoxetine and olanzapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to fluoxetine |
Causative agent (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 60 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 10 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine hydrochloride |
Is modification of (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoxetine (as fluoxetine hydrochloride) 4 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluoxetine and olanzapine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fluoxetine and olanzapine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine and olanzapine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 90 mg gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 25 mg and olanzapine 6 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluoxetine (as fluoxetine hydrochloride) 50 mg and olanzapine 6 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Fluoxetine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |